\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ examination\\:\\ \\ general\\ \\-\\ this\\ is\\ a\\ slightly\\ emaciated\\ african\\-american\\ male\\ who\\ appears\\ dehydrated\\.\\ \\ \ \(0\)\
\-\ vital\\ signs\\ \\-\\ afebrile\\.\\ \ \(0\)\
\-\ \\ \ \(1082074\)\
\-\ temperature\\ 97\\.4\\,\\ blood\\ pressure\\ 112\\/87\\,\\ pulse\\ 98\\,\\ respiratory\\ rate\\ 18\\.\ \(0\)\
\-\ the\\ patient\\ was\\ admitted\\ and\\ treated\\ with\\ ceftriaxone\\ and\\ zithromax\\ for\\ a\\ respiratory\\ tract\\ infection\\.\\ after\\ two\\ days\\ and\\ multiple\\ breathing\\ treatments\\ the\\ patient\\ was\\ encouraged\\ to\\ stop\\ smoking\\ as\\ quickly\\ possible\\ and\\ discharged\\ home\\.\ \(0\)\
\-\ findings\\ compatible\\ with\\ pulmonary\\ artery\\ hypertension\\ and\\ chronic\\ obstructive\\ pulmonary\\ disease\\.\ \(0\)\
\-\ pulmonary\\ arterial\\ hypertension\ \(11\)\
\-\ differential\\ diagnosis\\ of\\ enlarged\\ hila\ \(0\)\
\-\ \\Â\\·\\ adenopathy\\ \\(sarcoidosis\\,\\ lymphoma\\,\\ infection\\,\\ neoplasm\\)\ \(0\)\
\-\ \\Â\\·\\ malignancy\\ \\(primary\\ or\\ secondary\\)\ \(0\)\
\-\ \\Â\\·\\ pulmonary\\ arterial\\ hypertension\ \(0\)\
\-\ \\Â\\·\\ pulmonary\\ artery\\ aneurysm\\ \\(behcet\\'s\\ and\\ other\\ vasculidities\\)\ \(0\)\
\-\ this\\ is\\ a\\ 51\\-year\\-old\\ african\\-american\\ male\\ who\\ has\\ been\\ recently\\ diagnosed\\ with\\ pneumonia\\.\\ \\ he\\ also\\ presented\\ with\\ acute\\ neutropenia\\ and\\ nephrolithiasis\\,\\ currently\\ on\\ the\\ hospital\\'s\\ pneumonia\\ pathway\\.\\ \\ \ \(0\)\
\-\ past\\ medical\\ history\\:\\ \\ significant\\ for\\ chronic\\ obstructive\\ pulmonary\\ disease\\.\ \(0\)\
\-\ social\\ history\\:\\ \\ tobacco\\ use\\.\\ \\ denies\\ iv\\ drug\\ abuse\\.\ \(0\)\
\-\ common\\ findings\\ on\\ chest\\ radiograph\\ in\\ patients\\ with\\ pah\\:\ \(0\)\
\-\ enlarged\\ main\\ and\\ hilar\\ pulmonary\\ arteries\\ that\\ taper\\ rapidly\\ toward\\ the\\ periphery\ \(0\)\
\-\ enlargement\\ of\\ the\\ right\\ ventricle\\ on\\ lateral\\ view\\(obliteration\\ of\\ retrosternal\\ clear\\ space\\.\ \(0\)\
\-\ hypertension\\-induced\\ atherosclerosis\\ causes\\ calcification\\ in\\ the\\ pulmonary\\ arteries\\ \\(not\\ common\\)\ \(0\)\
\-\ criteria\\ for\\ pulmonary\\ artery\\ enlargement\\:\\ \ \(0\)\
\-\ transverse\\ diameter\\ of\\ proximal\\ interlobar\\ pulmonary\\ arteries\\ exceeding\\ 16\\ mm\\ on\\ pa\\ radiograph\ \(0\)\
\-\ right\\ interlobar\\ pa\\ greater\\ than\\ 25\\ mm\\ is\\ specific\\ for\\ primary\\ pulmonary\\ hypertension\ \(0\)\
\-\ defined\\ as\\ a\\ pulmonary\\ artery\\ systolic\\ pressure\\ greater\\ than\\ 30\\/15\\ mm\\ hg\\.\\ \ \(0\)\
\-\ the\\ etiology\\ of\\ primary\\ pulmonary\\ hypertension\\ is\\ unknown\\.\\ \ \(0\)\
\-\ secondary\\ pulmonary\\ hypertension\\ can\\ be\\ a\\ complication\\ of\\ many\\ pulmonary\\,\\ cardiac\\ and\\ extrathoracic\\ conditions\\.\\ \ \(0\)\
\-\ cor\\ pulmonale\\ is\\ enlargement\\ of\\ the\\ right\\ ventricle\\ as\\ a\\ consequence\\ of\\ disorders\\ of\\ the\\ respiratory\\ system\\.\ \(0\)\
\-\ pulmonary\\ hypertension\\ invariably\\ precedes\\ cor\\ pulmonale\\.\\ \ \(0\)\
\-\ unrelieved\\ pulmonary\\ hypertension\\,\\ regardless\\ of\\ the\\ underlying\\ cause\\,\\ leads\\ to\\ right\\ ventricular\\ failure\\.\\ \ \(0\)\
\-\ the\\ estimated\\ incidence\\ of\\ primary\\ pulmonary\\ hypertension\\ is\\ 1\\ to\\ 2\\ cases\\ per\\ 1\\ million\\ persons\\ in\\ the\\ general\\ population\\.\\ \ \(0\)\
\-\ hypoxia\\-induced\\ vasoconstriction\\ and\\ capillary\\ obliteration\\ occur\\ in\\ interstitial\\ lung\\ disease\\ and\\ chronic\\ obstructive\\ pulmonary\\ disease\\,\\ which\\ is\\ the\\ most\\ common\\ cause\\ of\\ pulmonary\\ hypertension\\.\\ \\ \\ \ \(0\)\
\-\ \\ \\ \ \(31891\)\
\-\ clinical\\ symptoms\ \(26\)\
\-\ dyspnea\\ \ \(68\)\
\-\ fatigue\\ \ \(32\)\
\-\ chest\\ pain\\ \ \(108\)\
\-\ exertional\\ syncope\\ \ \(0\)\
\-\ signs\\ of\\ right\\ heart\\ failure\\ \\(jvd\\,\\ ascites\\,\\ hepatomegaly\\)\\ \ \(0\)\
\-\ echocardiography\\ is\\ the\\ most\\ useful\\ imaging\\ modality\\ for\\ detecting\\ pulmonary\\ hypertension\\ and\\ excluding\\ underlying\\ cardiac\\ disease\\.\\ confirmation\\ of\\ pulmonary\\ hypertension\\ is\\ based\\ on\\ identification\\ of\\ tricuspid\\ regurgitation\\.\\ right\\ ventricular\\ dilatation\\ and\\ hypertrophy\\ are\\ late\\ findings\\.\\ \ \(0\)\
\-\ cardiac\\ catheterization\\ should\\ be\\ performed\\ in\\ patients\\ with\\ unexplained\\ pulmonary\\ hypertension\\ and\\ remains\\ the\\ gold\\ standard\\ for\\ its\\ diagnosis\\ and\\ quantification\\.\\ \ \(0\)\
\-\ an\\ easy\\ way\\ to\\ memorize\\ seconday\\ causes\\ of\\ pulmonary\\ artery\\ hypertension\\ is\\ through\\ the\\ mnemonic\\ vice\ \(0\)\
\-\ vasculitis\ \(67\)\
\-\ idiopathic\\ \\(pph\\)\ \(0\)\
\-\ chronic\\ emboli\\ and\\ chronic\\ lung\\ disease\ \(0\)\
\-\ emphysema\\ and\\ eisenmenger\\'s\\ syndrome\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pulmonary\\:\\ 0\\.542054995104541\ \(0\)\
\-\ hypertension\\:\\ 0\\.4252622792940395\ \(0\)\
\-\ and\\:\\ 0\\.1301619816336887\ \(0\)\
\-\ the\\:\\ 0\\.11829525005761513\ \(0\)\
\-\ of\\:\\ 0\\.11601831053365855\ \(0\)\
\-\ artery\\:\\ 0\\.11506247840874667\ \(0\)\
\-\ chronic\\:\\ 0\\.1099685596569184\ \(0\)\
\-\ interlobar\\:\\ 0\\.10660853005268926\ \(0\)\
\-\ pulmonale\\:\\ 0\\.10660853005268926\ \(0\)\
\-\ obstructive\\:\\ 0\\.10337349526678855\ \(0\)\
\-\ is\\:\\ 0\\.10147266604463762\ \(0\)\
\-\ cor\\:\\ 0\\.09523516523537612\ \(0\)\
\-\ disease\\:\\ 0\\.093321665834221\ \(0\)\
\-\ primary\\:\\ 0\\.09113484729808786\ \(0\)\
\-\ respiratory\\:\\ 0\\.08842217995286149\ \(0\)\
\-\ arteries\\:\\ 0\\.08822434314928215\ \(0\)\
\-\ obliteration\\:\\ 0\\.08570004554842947\ \(0\)\
\-\ enlargement\\:\\ 0\\.08522044619036048\ \(0\)\
\-\ cardiac\\:\\ 0\\.08254467825648622\ \(0\)\
\-\ mm\\:\\ 0\\.07955128912083173\ \(0\)\
\-\ right\\:\\ 0\\.07370798471277318\ \(0\)\
\-\ for\\:\\ 0\\.06738321702643044\ \(0\)\
\-\ common\\:\\ 0\\.06304020095067185\ \(0\)\
\-\ ventricular\\:\\ 0\\.0623366699713512\ \(0\)\
\-\ arterial\\:\\ 0\\.061028277406490763\ \(0\)\
\-\ underlying\\:\\ 0\\.0604948405750353\ \(0\)\
\-\ general\\:\\ 0\\.05948949712901678\ \(0\)\
\-\ vasculidities\\:\\ 0\\.059256110208061784\ \(0\)\
\-\ memorize\\:\\ 0\\.059256110208061784\ \(0\)\
\-\ pph\\:\\ 0\\.059256110208061784\ \(0\)\
\-\ pneumonia\\:\\ 0\\.05849224260242088\ \(0\)\
\-\ pa\\:\\ 0\\.056869991714300544\ \(0\)\
\-\ emaciated\\:\\ 0\\.056622376758513546\ \(0\)\
\-\ zithromax\\:\\ 0\\.056622376758513546\ \(0\)\
\-\ precedes\\:\\ 0\\.056622376758513546\ \(0\)\
\-\ seconday\\:\\ 0\\.056622376758513546\ \(0\)\
\-\ pressure\\:\\ 0\\.056425805819028764\ \(0\)\
\-\ failure\\:\\ 0\\.05626307502506507\ \(0\)\
\-\ causes\\:\\ 0\\.05599630647584888\ \(0\)\
\-\ on\\:\\ 0\\.055953490230196405\ \(0\)\
\-\ findings\\:\\ 0\\.054861699851507614\ \(0\)\
\-\ greater\\:\\ 0\\.054595902704089344\ \(0\)\
\-\ ventricle\\:\\ 0\\.05454857597833793\ \(0\)\
\-\ unrelieved\\:\\ 0\\.05330426502634463\ \(0\)\
\-\ quantification\\:\\ 0\\.05330426502634463\ \(0\)\
\-\ vice\\:\\ 0\\.05330426502634463\ \(0\)\
\-\ eisenmenger\\:\\ 0\\.05330426502634463\ \(0\)\
\-\ ceftriaxone\\:\\ 0\\.0521199796881008\ \(0\)\
\-\ pah\\:\\ 0\\.0521199796881008\ \(0\)\
\-\ million\\:\\ 0\\.0521199796881008\ \(0\)\
\-\ persons\\:\\ 0\\.0521199796881008\ \(0\)\
\-\ signs\\:\\ 0\\.05179218032730538\ \(0\)\
\-\ invariably\\:\\ 0\\.05111868070179359\ \(0\)\
\-\ vasoconstriction\\:\\ 0\\.05111868070179359\ \(0\)\
\-\ enlarged\\:\\ 0\\.050519300004247716\ \(0\)\
\-\ cause\\:\\ 0\\.050484702988191285\ \(0\)\
\-\ neutropenia\\:\\ 0\\.050251316067236304\ \(0\)\
\-\ taper\\:\\ 0\\.050251316067236304\ \(0\)\
\-\ exceeding\\:\\ 0\\.050251316067236304\ \(0\)\
\-\ excluding\\:\\ 0\\.050251316067236304\ \(0\)\
\-\ behcet\\:\\ 0\\.04948624623855256\ \(0\)\
\-\ extrathoracic\\:\\ 0\\.04948624623855256\ \(0\)\
\-\ unexplained\\:\\ 0\\.04948624623855256\ \(0\)\
\-\ mnemonic\\:\\ 0\\.04948624623855256\ \(0\)\
\-\ dehydrated\\:\\ 0\\.048801867955931895\ \(0\)\
\-\ radiograph\\:\\ 0\\.04826672270415514\ \(0\)\
\-\ easy\\:\\ 0\\.048182772493428755\ \(0\)\
\-\ hila\\:\\ 0\\.04761758261768806\ \(0\)\
\-\ consequence\\:\\ 0\\.04761758261768806\ \(0\)\
\-\ exertional\\:\\ 0\\.04761758261768806\ \(0\)\
\-\ pathway\\:\\ 0\\.04709765833227713\ \(0\)\
\-\ encouraged\\:\\ 0\\.046616283631380845\ \(0\)\
\-\ retrosternal\\:\\ 0\\.046616283631380845\ \(0\)\
\-\ hepatomegaly\\:\\ 0\\.04616813450638365\ \(0\)\
\-\ tricuspid\\:\\ 0\\.04616813450638365\ \(0\)\
\-\ in\\:\\ 0\\.0460881501915969\ \(0\)\
\-\ lung\\:\\ 0\\.045079762088233666\ \(0\)\
\-\ regardless\\:\\ 0\\.044983849168139814\ \(0\)\
\-\ infection\\:\\ 0\\.04476453621393217\ \(0\)\
\-\ as\\:\\ 0\\.04465673900990329\ \(0\)\
\-\ hg\\:\\ 0\\.04429947088551915\ \(0\)\
\-\ jvd\\:\\ 0\\.0439825501818326\ \(0\)\
\-\ secondary\\:\\ 0\\.043924714946873264\ \(0\)\
\-\ quickly\\:\\ 0\\.04368037542301602\ \(0\)\
\-\ syncope\\:\\ 0\\.04368037542301602\ \(0\)\
\-\ with\\:\\ 0\\.043532861792458785\ \(0\)\
\-\ stop\\:\\ 0\\.04311518554727532\ \(0\)\
\-\ detecting\\:\\ 0\\.042850022774214735\ \(0\)\
\-\ gold\\:\\ 0\\.0421138865609681\ \(0\)\
\-\ than\\:\\ 0\\.04200879484870727\ \(0\)\
\-\ who\\:\\ 0\\.04191913837242274\ \(0\)\
\-\ catheterization\\:\\ 0\\.04188594787789138\ \(0\)\
\-\ patients\\:\\ 0\\.041688886627319156\ \(0\)\
\-\ echocardiography\\:\\ 0\\.041665737435970907\ \(0\)\
\-\ atherosclerosis\\:\\ 0\\.04104664197346777\ \(0\)\
\-\ identification\\:\\ 0\\.04104664197346777\ \(0\)\
\-\ regurgitation\\:\\ 0\\.040481452097727084\ \(0\)\
\-\ confirmation\\:\\ 0\\.03963668082829817\ \(0\)\
\-\ tobacco\\:\\ 0\\.03932730874361989\ \(0\)\
\-\ chest\\:\\ 0\\.0391170979456793\ \(0\)\
\-\ nephrolithiasis\\:\\ 0\\.03888923810928017\ \(0\)\
\-\ capillary\\:\\ 0\\.03888923810928017\ \(0\)\
\-\ way\\:\\ 0\\.038749542705333866\ \(0\)\
\-\ abuse\\:\\ 0\\.03861278847686258\ \(0\)\
\-\ most\\:\\ 0\\.038567199575235335\ \(0\)\
\-\ social\\:\\ 0\\.03847885412511264\ \(0\)\
\-\ estimated\\:\\ 0\\.03847885412511264\ \(0\)\
\-\ diagnosis\\:\\ 0\\.0384162175373778\ \(0\)\
\-\ treatments\\:\\ 0\\.038347625703802\ \(0\)\
\-\ ascites\\:\\ 0\\.03821899603664708\ \(0\)\
\-\ toward\\:\\ 0\\.037969135004291964\ \(0\)\
\-\ temperature\\:\\ 0\\.03772853024129886\ \(0\)\
\-\ periphery\\:\\ 0\\.037383550807478634\ \(0\)\
\-\ leads\\:\\ 0\\.037383550807478634\ \(0\)\
\-\ systolic\\:\\ 0\\.037272512446743906\ \(0\)\
\-\ compatible\\:\\ 0\\.03705597286444393\ \(0\)\
\-\ rapidly\\:\\ 0\\.03705597286444393\ \(0\)\
\-\ to\\:\\ 0\\.03705289442288779\ \(0\)\
\-\ criteria\\:\\ 0\\.03674412485599809\ \(0\)\
\-\ modality\\:\\ 0\\.036643416080147234\ \(0\)\
\-\ emboli\\:\\ 0\\.03635033241578258\ \(0\)\
\-\ emphysema\\:\\ 0\\.03635033241578258\ \(0\)\
\-\ breathing\\:\\ 0\\.03625550465973192\ \(0\)\
\-\ 98\\:\\ 0\\.0358894593182043\ \(0\)\
\-\ fatigue\\:\\ 0\\.0358894593182043\ \(0\)\
\-\ useful\\:\\ 0\\.03537638330535771\ \(0\)\
\-\ remains\\:\\ 0\\.03529467674469367\ \(0\)\
\-\ population\\:\\ 0\\.035055548419012435\ \(0\)\
\-\ pulse\\:\\ 0\\.03497775604100712\ \(0\)\
\-\ late\\:\\ 0\\.03497775604100712\ \(0\)\
\-\ hypertrophy\\:\\ 0\\.03490088430447817\ \(0\)\
\-\ standard\\:\\ 0\\.03438684103886743\ \(0\)\
\-\ vasculitis\\:\\ 0\\.03438684103886743\ \(0\)\
\-\ smoking\\:\\ 0\\.03431661780437807\ \(0\)\
\-\ hilar\\:\\ 0\\.0339764570546999\ \(0\)\
\-\ conditions\\:\\ 0\\.033845228633389256\ \(0\)\
\-\ drug\\:\\ 0\\.033716598966234336\ \(0\)\
\-\ complication\\:\\ 0\\.033653226893571565\ \(0\)\
\-\ interstitial\\:\\ 0\\.03359046712103891\ \(0\)\
\-\ male\\:\\ 0\\.03299500716522341\ \(0\)\
\-\ vital\\:\\ 0\\.03299412329624673\ \(0\)\
\-\ home\\:\\ 0\\.03277011537633116\ \(0\)\
\-\ disorders\\:\\ 0\\.03271529997992712\ \(0\)\
\-\ dyspnea\\:\\ 0\\.03260703770838298\ \(0\)\
\-\ recently\\:\\ 0\\.032344022591458875\ \(0\)\
\-\ main\\:\\ 0\\.03229267381871315\ \(0\)\
\-\ afebrile\\:\\ 0\\.03199282430993951\ \(0\)\
\-\ incidence\\:\\ 0\\.03189587346646168\ \(0\)\
\-\ discharged\\:\\ 0\\.031800348422457415\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.031387062247791565\ \(0\)\
\-\ idiopathic\\:\\ 0\\.031342723605151654\ \(0\)\
\-\ adenopathy\\:\\ 0\\.0311683349856756\ \(0\)\
\-\ tract\\:\\ 0\\.031040548846335073\ \(0\)\
\-\ per\\:\\ 0\\.030751808603011962\ \(0\)\
\-\ admitted\\:\\ 0\\.030360389846698484\ \(0\)\
\-\ dilatation\\:\\ 0\\.03024742028751765\ \(0\)\
\-\ be\\:\\ 0\\.03006199214974023\ \(0\)\
\-\ denies\\:\\ 0\\.029884443968454688\ \(0\)\
\-\ etiology\\:\\ 0\\.029849237454485058\ \(0\)\
\-\ diameter\\:\\ 0\\.029779391771562292\ \(0\)\
\-\ many\\:\\ 0\\.029214201895821596\ \(0\)\
\-\ slightly\\:\\ 0\\.028903348998205063\ \(0\)\
\-\ 16\\:\\ 0\\.028873066491489997\ \(0\)\
\-\ transverse\\:\\ 0\\.028548956427993044\ \(0\)\
\-\ currently\\:\\ 0\\.02846329910857839\ \(0\)\
\-\ use\\:\\ 0\\.028350818619602633\ \(0\)\
\-\ history\\:\\ 0\\.02831292383739158\ \(0\)\
\-\ system\\:\\ 0\\.028267718305918423\ \(0\)\
\-\ aneurysm\\:\\ 0\\.028212902909514382\ \(0\)\
\-\ rate\\:\\ 0\\.02807785467866961\ \(0\)\
\-\ specific\\:\\ 0\\.02807785467866961\ \(0\)\
\-\ unknown\\:\\ 0\\.02807785467866961\ \(0\)\
\-\ malignancy\\:\\ 0\\.027739330715172608\ \(0\)\
\-\ its\\:\\ 0\\.02741757878335289\ \(0\)\
\-\ hospital\\:\\ 0\\.027369463112043715\ \(0\)\
\-\ occur\\:\\ 0\\.027250710518906443\ \(0\)\
\-\ appears\\:\\ 0\\.02713409004482354\ \(0\)\
\-\ view\\:\\ 0\\.02713409004482354\ \(0\)\
\-\ clear\\:\\ 0\\.026862458024379077\ \(0\)\
\-\ diagnosed\\:\\ 0\\.026840326534738914\ \(0\)\
\-\ based\\:\\ 0\\.026840326534738914\ \(0\)\
\-\ iv\\:\\ 0\\.026475189222279056\ \(0\)\
\-\ calcification\\:\\ 0\\.026454336601077925\ \(0\)\
\-\ defined\\:\\ 0\\.026433550708378703\ \(0\)\
\-\ 25\\:\\ 0\\.026249411532599225\ \(0\)\
\-\ was\\:\\ 0\\.02582680402089346\ \(0\)\
\-\ heart\\:\\ 0\\.025763715563603268\ \(0\)\
\-\ this\\:\\ 0\\.025464283661407072\ \(0\)\
\-\ neoplasm\\:\\ 0\\.025294385838514524\ \(0\)\
\-\ possible\\:\\ 0\\.02510559726562436\ \(0\)\
\-\ cases\\:\\ 0\\.024922141053227813\ \(0\)\
\-\ space\\:\\ 0\\.02466421790249643\ \(0\)\
\-\ should\\:\\ 0\\.02417720124352321\ \(0\)\
\-\ past\\:\\ 0\\.02411881356116883\ \(0\)\
\-\ patient\\:\\ 0\\.024103082299548897\ \(0\)\
\-\ differential\\:\\ 0\\.024075364663880026\ \(0\)\
\-\ examination\\:\\ 0\\.02371050583910164\ \(0\)\
\-\ medical\\:\\ 0\\.023548781653205713\ \(0\)\
\-\ clinical\\:\\ 0\\.023482567156024915\ \(0\)\
\-\ days\\:\\ 0\\.023456269201376893\ \(0\)\
\-\ proximal\\:\\ 0\\.023148728406794092\ \(0\)\
\-\ treated\\:\\ 0\\.023074065677572808\ \(0\)\
\-\ syndrome\\:\\ 0\\.022337929464326178\ \(0\)\
\-\ lymphoma\\:\\ 0\\.022067466335259047\ \(0\)\
\-\ through\\:\\ 0\\.02205687858079489\ \(0\)\
\-\ two\\:\\ 0\\.02200419714096566\ \(0\)\
\-\ he\\:\\ 0\\.021941538269954947\ \(0\)\
\-\ performed\\:\\ 0\\.021920785581613696\ \(0\)\
\-\ presented\\:\\ 0\\.021607319058240183\ \(0\)\
\-\ been\\:\\ 0\\.021587605580512398\ \(0\)\
\-\ blood\\:\\ 0\\.02151907577910976\ \(0\)\
\-\ significant\\:\\ 0\\.02139369309323995\ \(0\)\
\-\ symptoms\\:\\ 0\\.020273404193106158\ \(0\)\
\-\ physical\\:\\ 0\\.020091087800009358\ \(0\)\
\-\ acute\\:\\ 0\\.020044356764456102\ \(0\)\
\-\ imaging\\:\\ 0\\.01947270297542888\ \(0\)\
\-\ can\\:\\ 0\\.019444337926312373\ \(0\)\
\-\ other\\:\\ 0\\.019242314144865224\ \(0\)\
\-\ lateral\\:\\ 0\\.018388682255223457\ \(0\)\
\-\ multiple\\:\\ 0\\.018123519482162873\ \(0\)\
\-\ after\\:\\ 0\\.01797510772380826\ \(0\)\
\-\ also\\:\\ 0\\.017428756567553223\ \(0\)\
\-\ has\\:\\ 0\\.016924815523291406\ \(0\)\
\-\ which\\:\\ 0\\.01684845213475538\ \(0\)\
\-\ that\\:\\ 0\\.016079692979713442\ \(0\)\
\-\ not\\:\\ 0\\.014627716255157505\ \(0\)\
\-\ an\\:\\ 0\\.014169013779462615\ \(0\)\
\-\ are\\:\\ 0\\.014059998750125327\ \(0\)\
\-\ pain\\:\\ 0\\.013258993398285549\ \(0\)\
\-\ or\\:\\ 0\\.012890143472236586\ \(0\)\
